NE of the greatest challenges in neurosurgery of gliomas is encountered when one attempts to achieve as complete a resection as possible while preserving normal brain tissue and function. To minimize postoperative complications, information about the localization and spatial extent of the lesion itself and the functional organization of the adjacent brain should be available before and during the surgical procedure. The increasing availability and routine application of frameless stereotactic methods (also known as neuronavigation) in neurosurgery have been used as a platform to integrate functional information in the operating room, leading to what is known as functional neuronavigation. Several studies have been reported in which magnetoencephalography, 6, 7, 10 functional MR imaging, 11, 20, 27 and positron emission tomography 1,5 were used as noninvasive and efficient tools to locate essential functional areas of the brain pre-and intraoperatively. On the other hand, when using conventional MR imaging it is often difficult to delineate the heterogeneous structure of a lesion, especially that of a glioma. Even the current method of choice-contrast-enhanced MR imaging as a technique for visualizing regions in which the blood-brain barrier is damaged-is not specific for tumors and can result in ambiguous or misleading findings. 3, 13 Establishing the position and size of the border zone between the tumor and normal brain tissue is a major problem faced in treatment planning. Proton MR spectroscopy is a noninvasive tool used to investigate the spatial distribution of metabolic changes in brain lesions. Several authors have reported increased levels of Cho-containing compounds and a reduction in the signal intensities of NAA and Cr in brain tumors. 4, 18, 21, 22 Choline-containing compounds are thought to be markers for increased membrane turnover or higher cellular density, 17 NAA is mainly contained within neurons, 31 and Cr is a marker of energy metabolism. 12 The ranges of Cho increase and NAA decrease seem compatible with the range of tumor infiltration.
and positron emission tomography 1, 5 were used as noninvasive and efficient tools to locate essential functional areas of the brain pre-and intraoperatively. On the other hand, when using conventional MR imaging it is often difficult to delineate the heterogeneous structure of a lesion, especially that of a glioma. Even the current method of choice-contrast-enhanced MR imaging as a technique for visualizing regions in which the blood-brain barrier is damaged-is not specific for tumors and can result in ambiguous or misleading findings. 3, 13 Establishing the position and size of the border zone between the tumor and normal brain tissue is a major problem faced in treatment planning. Proton MR spectroscopy is a noninvasive tool used to investigate the spatial distribution of metabolic changes in brain lesions. Several authors have reported increased levels of Cho-containing compounds and a reduction in the signal intensities of NAA and Cr in brain tumors. 4, 18, 21, 22 Choline-containing compounds are thought to be markers for increased membrane turnover or higher cellular density, 17 NAA is mainly contained within neurons, 31 and Cr is a marker of energy metabolism. 12 The ranges of Cho increase and NAA decrease seem compatible with the range of tumor infiltration. 2, 3 The calculation of "metabolic maps" by integrating the peak area of a metabolite of interest for each voxel is a common method to visualize these changes. 14, 30, 32 In princi-ple, metabolic maps of NAA and Cho allow the differentiation of necrosis, solid tumor, and varying degrees of tumor infiltration as well as tissue edema. Using standard spectroscopy imaging techniques at 1.5 teslas, that is, selecting nominal voxel sizes of approximately 1 cm 3 or larger, the spatial resolution and, therefore, the contrast between tumor and normal or edematous brain tissue, however, is not sufficient, especially for the delineation of the tumor infiltration zone.
In this initial study we performed with an adequate spatial resolution comparable to the accuracy of a previously described neuronavigation system 29 and computerized images of Cho/NAA ratios were used to improve the contrast between apparently normal tissue and tumor. We developed software to achieve automated segmentation of the tumor including the infiltration zone in this ratio map. The MR spectroscopy slab was coregistered to anatomical images and a so-called hybrid data set, consisting of MR images and MR spectroscopy imaging data, was created and matched exactly to a 3D data set for use with frameless stereotaxy. With this method the border zone between the tumor and normal brain tissue can be intraoperatively visualized by projecting the image through the navigation microscope. It allows the clinician at the same time to coregister 1 H-MR spectroscopy-guided biopsy samples with the stereotactic virtual space of the MR imaging data and the physical space of the surgical site. The histopathological findings of these biopsy specimens can be exactly correlated to the voxel in the MR imaging/MR spectroscopy hybrid data set.
Materials and Methods

Three-Dimensional MR Imaging and 1 H-MR Spectroscopy
All MR imaging studies were performed using a 1.5-tesla clinical whole-body imaging unit (Magnetom Sonata; Siemens, Erlangen, Germany) equipped with a standard head coil. During each MR spectroscopy session, which was performed the day before surgery, a localization image and an axial SE sequence (T 1 -weighted) were acquired for MR spectroscopy excitation volume location. The SE sequence was used to match the spectroscopic images to an anatomical 3D MR image set. The following parameters were used: 500 msec TR, 15 msec TE, a 256 ϫ 256 matrix size, 16 ϫ 16-cm FOV, and 20 slices with a distance factor of 0% and a slice thickness of 2 mm. The MR spectroscopy sequence, in which point-resolved spectroscopy volume preselection was used, was performed immediately afterward. Water suppression was achieved using three chemical shift-selective pulses before the point-resolved spectroscopy excitation. The MR spectroscopy parameters included the following: 1600 msec TR, 135 msec TE, a 24 ϫ 24 circular phase-encoding scheme across a 16 ϫ 16-cm FOV, a slice thickness of 10 mm, a 50% Hamming filter and two excitations, a spectral width of 1000 Hz, and a 1024 complex point acquisition size. The total spectroscopic data acquisition time took less than 13 minutes. The nominal voxel size for data acquisition was 0.67 ϫ 0.67 ϫ 1 cm 3 (~0.45 cm 3 resolution). After zero filling to a 32 ϫ 32 matrix size, the volume of a voxel was 0.25 cm 3 . The MR spectroscopy slab was aligned precisely to a selected SE slice by copying and pasting of the image position. Because the same FOV was used in the SE sequence and the MR spectroscopy experiment, and with the assumption of negligible head and brain motion between the time of the MR imaging and MR spectroscopy imaging acquisition, a direct correlation between data on the MR spectroscopy slab (10 mm thick) and five slices (each 2 mm thick) of the anatomical MR image was achieved. Immobilization of each patient's head was achieved by fixation in a headrest. In a single session, which took place 1 day before surgery, a 3D anatomical MPRAGE sequence was performed using the following parameters: 2020 msec TR, 4.38 msec TE, a 25 ϫ 25-cm FOV, 1 mm isotropic resolution, and 160 slices. For registration in the neuronavigation system, between six and eight adhesive skin fiducial markers were placed in a scattered pattern on the surface of the patient's head prior to imaging.
Magnetic Resonance Spectroscopy Data Analysis
Zero filling to a 32 ϫ 32 matrix size and two-dimensional spatial Fourier transformation were performed using data-processing software (Syngo MR 2002A; Siemens) provided by the manufacturer of the MR imaging unit. Magnetic resonance spectroscopy raw data sets lacking any header information were processed using the freely available reconstruction program csx (designed for use with Linux and obtained from PB Barker, Baltimore, MD). Spectroscopic imaging data were exponentially filtered using a line-broadening factor of 3 Hz, zero filled to 2048 data points, and Fourier transformed with respect to the spectral dimension. To remove the residual water peak we used a high-pass convolution filter (50-Hz stop band). 9 The magnitude spectra were calculated, the position of NAA set to 2.02 ppm, and a susceptibility correction was applied. The peak areas for Cho, Cr, and NAA were calculated by performing integration over frequency ranges of 3.34 Ϯ 3.14 ppm, 3.14 Ϯ 2.94 ppm, and 2.22 Ϯ 1.82 ppm, respectively. Smooth linear interpolation to a 256 ϫ 256 matrix resulted in the metabolic maps. Images of Cho and NAA ( Fig.  1A and B) were used to calculate a map of Cho/NAA ratios (Fig.  1C) . We assumed that the values for the Cho/NAA ratio in the normal brain follow a gaussian distribution, and that these values for the tumor, including the border zone, are significantly increased. These assumptions represent the basis on which our tumor segmentation procedure was developed. For MR spectroscopy studies, the volume of interest covered as much normal brain as possible in addition to the bulk of the tumor. For segmentation we determined a "healthy region" of predominantly white matter located on the contralateral side and at a sufficient distance from the lesion according to the Cho/ NAA ratio map (red rectangle in Fig. 1C ). The mean and the SD of the Cho/NAA ratios were calculated for the selected region and all Cho/NAA values in the whole map that were lower than the mean Ϯ three SDs were set to zero. This leads to the elimination of all normal brain areas in the Cho/NAA map and, hence, to the segmentation of the tumor (Fig. 1D) . Experiments for testing and validation of the described segmentation procedure are not part of this study and will be published in greater detail. 28 
The MR Imaging/MR Spectroscopy Hybrid Data Set and Frameless Stereotaxy
The MR imaging/MR spectroscopy hybrid data set was obtained by replacing the raw data of the images of the five anatomical slices in the SE data set, which were correlated with the MR spectroscopy slice by copying the 3D coordinates, with the corresponding Cho/ NAA ratio map of the segmented tumor (Fig. 2) . On the evening before surgery this hybrid data set and the 3D MPRAGE data set (containing information on the position of the fiducial marker) were transferred via ethernet to a frameless stereotactic system (VectorVisionSky [BrainLAB, Heimstetten, Germany] connected to a NC4-Multivision navigation microscope [Zeiss, Oberkochen, Germany]) by using the DICOM 3 protocol. At this point both the hybrid and the MPRAGE data sets were fused using a mutual-information algorithm, which is part of the software provided with the frameless stereotactic system (VV2 Planning, Version 1.3; BrainLAB). The fact that the hybrid data set contains anatomical and biochemical information bypassed the problem that the metabolic maps did not provide enough anatomical information for a mutual-information algorithm. As a result a new 3D data set containing biochemical as well as anatomical information was created (Fig. 3) . This navigation data set was used for all further surgical and stereotactic procedures. In our protocol we performed a craniotomy and, before tumor resection, biopsy samples were obtained using a needle registered to the stereotactic system. The targets for these biopsies were chosen according to the metabolic maps: the region of maximal pathological changes in the metabolic map and the transition site between spectroscopically pathological and spectroscopically normal regions (Fig.  4) . Needle biopsies were performed because, at this stage of surgery, no or negligible brain shift had occurred. The biopsy samples were evaluated by a neuropathologist and correlated to the MR spectroscopy findings as part of an ongoing study. After biopsy sampling, tumor resection followed using the navigation data set and a navigation microscope.
Results
High-resolution spectroscopy data of good quality have been obtained from 17 patients. Analyses of the MR spec-troscopy data, including the calculation of metabolic maps and segmentation, and the integration of these MR spectroscopy results into functional neuronavigation, accomplished using the technique we present here, were successfully performed in all cases as part of a preliminary technical feasibility study on our technique. Four of the patients underwent resection along with MR spectroscopyguided frameless stereotaxy and biopsy sampling. Presently we are collecting more data to be presented in a future clinical study. Our preliminary data revealed that biopsies from the center of the site of maximal pathological metabolic changes exhibited a range of tumor infiltration varying from 85 to 100% (89 Ϯ 9% [mean Ϯ SD]). Biopsy results from the transition area of spectroscopically pathological voxels revealed tumor infiltration ranging from 5 to 15% (9 Ϯ 5% [mean Ϯ SD]). In two cases biopsy samples from within spectroscopically normal areas displayed less than 5% tumor infiltration.
The precision and accuracy of the method were validated by inspection of the congruency of structural details between the anatomical slices in the hybrid dataset and the 3D MPRAGE data set. The total time spent performing this procedure was approximately 1 hour. This was divided into 20 minutes for conventional MR imaging (SE sequence) and MR spectroscopy data acquisition, 30 minutes for MR spectroscopy data analysis, and 10 minutes for obtaining the MR imaging/MR spectroscopy hybrid data set.
Illustrative Case
Examination. This 34-year-old woman presented after a single generalized seizure. A neuroimaging examination revealed a hypointense lesion in the left frontal lobe and a low-grade glioma was suspected. Initially the patient rejected surgery, received antiepileptic treatment, and was kept under observation. On a follow-up MR imaging study the lesion displayed moderate contrast enhancement, and surgery was proposed. Neurological examination revealed no additional deficits.
Operation. During surgery a lesion in the left frontal lobe was identified using MR spectroscopy-guided functional navigation. The intraoperative visualization of the MR spectroscopy data on the tumor, which was displayed through the eyepieces of the microscope (Fig. 4A) The same data set after these five anatomical slices have been replaced with five copies of metabolic map, located in the exact position within the examined brain. This leads to a modified new data set that we call the "hybrid data set." MRSI = MR spectroscopy image.
Discussion
A number of recent papers have contained descriptions of the integration of functional information, such as that provided by magnetoencephalography 6, 7, 10 and functional MR imaging, 11, 20, 27 into frameless stereotaxy. This implementation of functional imaging and navigation, so-called functional neuronavigation, includes both anatomical and functional data and allows the fast identification of eloquent areas of the brain. Nevertheless, the heterogeneity and poorly defined tumor margins typically displayed on conventional MR images still pose a challenge to treatment planning. Proton MR spectroscopy allows the delineation of the spatial distribution of metabolic changes due to focal lesions.
In this report, we present a technique for the integration of information provided by high-resolution 1 H-MR spectroscopy into the neurosurgical operating room. In particular, we show the segmentation of brain tumors on spectroscopic images. The map of the segmented tumor was used for selection of biopsy targets. In contrast to the approach by McKnight, et al., 16 we used magnitude spectra and peak areas to qualify the metabolite levels. Ratios of individual Cho and NAA peak areas resulted in a reduction of noise levels in most parts of the brain. We used a combined imaging data set consisting of conventional MR imaging slices and segmented metabolic maps of the MR spectroscopy slice, a so-called MR imaging/MR spectroscopy hybrid data set, to merge biochemical information into a global 3D MR image. Drawing regions of interest based on metabolic im-
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Frameless stereotaxy with MR spectroscopic imaging
The DICOM transfer and image fusion of the MR imaging/MR spectroscopy hybrid data set and a 3D MPRAGE data set. The hybrid data set and a 3D MPRAGE data set are transferred to a workstation for image fusion by a commercially available software (VV2 Planning, Version 1.3; BrainLAB). This fusion delivers the final MR data set that is used for frameless stereotaxy. Lower: Axial, sagittal, and coronal views of this data set with the hybrid data set fused to the 3D MPRAGE data set. The quality of the fusion is documented by the congruent alignment of the sulci.
ages allows intraoperative visualization of these regions displayed through the eyepieces of the microscope, leading to a MR spectroscopy-guided tumor resection.
Only a few papers contain descriptions of the use of MR spectroscopy to support biopsy target delineation 2, 3, 8, 16, 26 or radiation therapy treatment planning. 19, 23, 24 In all the studies outlined in those papers as well as in our approach, the strategy was based on the sequential acquisition of MR spectroscopy and MR imaging data sets and, therefore, the assumption of negligible patient movement between images. A headrest provides the immobilization of the patient's head. Nevertheless, the most critical time period consists of the few seconds between the completion of one image and the initiation of the next; if a patient moves during acquisition of a single image an artifact reveals the movement. In contrast to our approach authors of previously published studies have used 3D coordinates for coregistration of the MR imaging and MR spectroscopy data sets. In none of the cited studies have MR spectroscopy data been integrated into a neuronavigation system and visualization of MR spectroscopy data performed intraoperatively through image injection. Preul, et al., 25 data (metabolic maps of Cho) of two patients into an image-guided, frameless stereotactic system by computing a transformation between the MR spectroscopy space and the global MR imaging space by using the targeting volume acquired immediately before MR spectroscopy acquisition. Using this approach they overcame the fact that MR spectroscopy lacks detailed structural information. The advantage of our method of coregistration of MR spectroscopy images to anatomical images lies in a technique in which the coordinate system of the imaging unit is used for coregistration and does not depend on other registration algorithms that may introduce additional errors. This relatively simple approach of copying and pasting of coordinates and the exchange of raw data from slices acquired in the same position and the same FOV may be easily applied by others.
Our strategy for merging MR spectroscopy data with a global 3D MR imaging data set was the full, accurate integration of metabolic images with coregistered anatomical images (MR imaging/MR spectroscopy hybrid data set), which results in a data set consisting of both anatomical and biochemical information. Additionally, we were able to test the precision and accuracy of our method qualitatively by inspecting the congruency of anatomical details. This is not the case in previous approaches in which the transformation of metabolic data sets into anatomical ones has been achieved by coordinate transfer or retrospective alignment of data.
The accuracy of the proposed method, that is, whether a voxel containing metabolic information really matches a voxel containing anatomical information, depends on several issues. The accuracy of the alignment of the 1 H-MR spectroscopy slab to the anatomical data set acquired with the same FOV on the basis of the raw images assumes that no head movement has occurred between acquisition of the two images. Under this assumption coregistration of the hybrid data set with the MPRAGE sequence used for stereotaxy is performed using a mutual-information algorithm and is carried out without user intervention. Mutual information is an information-theoretic approach for the registration of volumetric medical images of different modalities based on stochastic approximation. The accuracy of mutual-information algorithms can reach subvoxel range under ideal conditions. 15 Intraoperative accuracy of the metabolic data depends on the widely known and understood features of frameless stereotaxy: registration error, technical accuracy, overall accuracy, and brain shift. Especially because of the latter, a frame-based stereotactic biopsy is superior to a biopsy obtained during tumor resection.
Integration of biochemical information obtained with high-resolution 1 H-MR spectroscopy and frameless stereotaxy may be useful in glioma resection, leading to a better delineation of the tumor infiltration zone. This method also has the potential for a further investigation of the relationship between histopathological findings of an intraoperative biopsy at a given point in stereotactic space and the corresponding stereotactic coordinates of an anatomical/metabolic image defined by the frameless stereotactic systems.
